AAAngel Arizpe

Angel Arizpe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Angel Arizpe has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Changing Population and Ancestry Admixture Affects the Demographic Shifts in Lung Cancer Incidence

    by Sarah Gorbatov, Jorge Nieva, Albert Farias, Angel Arizpe

    Introduction: Despite declining smoking rates in both sexes in the US, lung cancer (LC) incidence has fallen faster in men than women and is now more common in young women. This study examined cross-national variation in LC incidence and evaluated population replacement and genomic admixture as alternative explanations. Methods: Sex-specific age-standardized smoking prevalence (IHME, year 2000) and LC incidence (GLOBOCAN 2022) were obtained for 96 countries. Male:Female smoking ratios (MFSR), lung cancer incidence ratios (LCIR), and discordance ratios (LCIR/MFSR) were analyzed using log-log linear regression.Results:The MFSR was positively associated with the LCIR (slope = 0.26, 95% CI: 0.15–0.36; R² = 0.19, p < 0.001). Southern European nations showed the greatest discordance, whereas East Asian countries fell below parity. In the U.S. population replacement analysis, female LC incidence in Latin American countries ranged from 3.8 to 12.1 per 100,000, substantially lower than the U.S. rate of 30.4 per 100,000. In a genomic admixture analysis of seven Latin American countries, European ancestry was positively correlated with female LC incidence (r = 0.83, p = 0.021), while Native American ancestry inversely correlated (r = −0.77, p = 0.043), with both associations persisting after smoking adjustment.Conclusions: Sex differences in tobacco use explain less than one-fifth of cross-national variance in the gender gap and are insufficient to explain elevated female rates across high-income countries. Admixture associations persisted after smoking adjustment, suggesting tobacco-independent exposures disproportionately affect women. Findings highlight the need to identify tobacco-independent factors contributing to elevated female LC risk.

  • Open Access

    Eligibility criteria and study phase limit racial/ethnic enrollment in oncology clinical trials

    by Angel Arizpe, Jorge Nieva, Trevor A. Pickering, Lihua Liu, Lauren Scampavia, Jenny Ferrin, Albert J. Farias

    Racial/ethnic minority enrollment in oncological therapeutic clinical trials (TCT) remains low. Thus, we explored whether TCTs’ restrictiveness enrol


  • Open Access

    Disparities in multidimensional psychosocial stressors by sexual identity among cancer survivors from the All of Us Research Program

    by Angel Arizpe, Nikta Saeedi, Carol Y. Ochoa-Dominguez, Theresa A. Hastert, Alberto Carvajal, Sue E. Kim, Albert J. Farias

    Objectives: To examine disparities in psychosocial stressors by sexual identity among cancer survivors and whether these differ by state governmental leaning. Methods: Cross-sectional data (2018–2022) from 14,806 cancer survivors in the All of Us repository were analyzed. Sexual identity (heterosexual vs. sexual minority) was examined in relation to discrimination in medical settings (DMS), perceived stress (PS), and neighborhood social cohesion (NSC) using multivariable logistic regression models adjusted for sociodemographic and clinical covariates, stratified by state governmental leaning. Results: 6.3% of survivors identified as sexual minority (SM). Compared with heterosexual survivors, SM individuals had higher odds of medium/high perceived stress (aOR = 1.46, 95% CI 1.26–1.72) and low neighborhood social cohesion (aOR = 1.47, 95% CI 1.27–1.71). In Republican-leaning states, they had over twice the odds of medical discrimination (aOR = 2.31; 95% CI = 1.50–3.71), with no association in Democratic-leaning states. Conclusions: Sexual minority cancer survivors experience greater psychosocial stressors regardless of their state’s governmental leaning, which may impact their cancer survivorship. Those in Republican-leaning states are more likely to have DMS experiences, potentially affecting their access to care and overall health. Future research should explore the long-term effects of policy environments and their influence on discrimination and psychosocial stress among SM cancer survivors.

  • Socioecological Factors Associated With Lung Cancer Clinical Trial Participation: Real-world California Cancer Registry Data

    by Angel Arizpe, Jorge Nieva, Lihua Liu, Trevor A. Pickering, Albert J. Farias


  • Open Access

    Supplementary Table 1 from Alcohol and Cannabis Use Associated with Cardiometabolic Biomarkers among “All of Us” Cancer Survivors

    by Angel Arizpe, Tiffany M. Chapman, Claudia Rodriguez, Alberto Carvajal, Katelyn J. Queen, Stephanie Navarro, Carol Y. Ochoa-Dominguez, Sue E. Kim, Claudia M. Toledo-Corral, Albert J. Farias

    Supplementary Table 1: Shows the distribution of cancer survivors excluded compared to those included in our final sample by all study variables

  • Open Access

    Data from Alcohol and Cannabis Use Associated with Cardiometabolic Biomarkers among “All of Us” Cancer Survivors

    by Angel Arizpe, Tiffany M. Chapman, Claudia Rodriguez, Alberto Carvajal, Katelyn J. Queen, Stephanie Navarro, Carol Y. Ochoa-Dominguez, Sue E. Kim, Claudia M. Toledo-Corral, Albert J. Farias

    Background:Cancer survivors are at increased risk for cardiometabolic comorbidities following cancer treatment, which may be further exacerbated by cannabis and alcohol use. We aimed to examine the direct relationships of cannabis, alcohol, and the co-use of both substances with cardiometabolic risk factors and to explore disparities by race/ethnicity and sex.Methods:Cross-sectional data were extracted from adult cancer survivors in the “All of Us” from 2018 to 2022. Cannabis use was defined as occasional or frequent/regular cannabis use (vs. never) in the past 3 months and hazardous alcohol intake (AUDIT-C >3 for females; AUDIT-C >4 for males) versus nonhazardous in the past year, respectively. Co-use was defined as participants who engaged in regular cannabis and hazardous alcohol intake. We identified binary cardiovascular, immune, and metabolic system biomarkers, with high values defined by clinically established cutoffs or >75th percentile. We used multivariable logistic regression adjusting for sociodemographic and clinical factors.Results:In our sample (N = 7,054), 7.6% were Hispanic, 6.2% were Black, and 86.2% were White cancer survivors. Less than 5% of Hispanic and White survivors reported substance co-use compared with 7% of Black survivors. Compared with never-users, co-users were 1.58 (95% confidence interval, 1.14–2.19) more likely to have high blood pressure. No significant associations were found between co-use and immune biomarkers or sex differences.Conclusions:Co-use of cannabis and hazardous alcohol may worsen high blood pressure in survivors, who are at higher risk for cardiometabolic comorbidities.Impact:The study investigates substance use and cardiometabolic biomarkers, urging much research on their effects on cancer survivors.

  • Open Access

    Supplementary Table 2 from Alcohol and Cannabis Use Associated with Cardiometabolic Biomarkers among “All of Us” Cancer Survivors

    by Angel Arizpe, Tiffany M. Chapman, Claudia Rodriguez, Alberto Carvajal, Katelyn J. Queen, Stephanie Navarro, Carol Y. Ochoa-Dominguez, Sue E. Kim, Claudia M. Toledo-Corral, Albert J. Farias

    Supplementary Table 2: Exploration of missing outcome data by exposure variables

  • Open Access

    Early COVID‐19 Vaccine Initiation and Completion Among Cancer Survivors and Barriers to Vaccine Completion: Implications for Future COVID‐19 Vaccination Uptake Rates

    by Nikta Saeedi, Angel Arizpe, Katelyn J. Queen, Jennifer Tsui, Sue Kim, Brian Z. Huang, Albert J. Farias

    Purpose: Cancer survivors are considered by public health officials as a high‐risk group in the United States for severe complications from COVID‐19. We aimed to characterize patterns of early uptake of the COVID‐19 vaccine among cancer survivors and to determine modifiable barriers to vaccine completion that can be addressed to ensure future booster adherence.Methods: Cross‐sectional data of vaccine uptake by summer 2021 was extracted from adult cancer survivors enrolled in the “All of Us” research program. Vaccine completion was determined based on receiving at least two doses. We assessed sociodemographic factors, socioeconomic barriers (education, income, health insurance status, housing, and employment status), and COVID‐19 vaccine uptake by Summer 2021, employing multivariable ordinal logistic regression for those who were unvaccinated, had initiated vaccine uptake, and had completed COVID‐19 vaccination.Results: Of the 514 cancer survivors in the sample, 73.7% were fully vaccinated by summer 2021. Those who received no vaccine doses showed higher proportions of SES barriers, medical distrust, and perceived lack of need barriers. Race (non‐Hispanic White vs. other) was not statistically significantly associated with vaccine uptake (OR (95% CI) = 0.94 (0.51, 1.70)), while for every additional SES barrier, there was a 40% decrease (OR (95% CI) = 0.60 (0.48, 0.75)) in the odds of receiving more COVID‐19 vaccine doses. Higher medical distrust and perceived lack of need were associated with 56% (OR = 0.44, 95% CI: 0.32–0.59) and 39% (OR = 0.61, 95% CI: 0.43–0.87) lower odds, respectively.Conclusion: Racial/ethnic disparities in vaccine uptake may be explained by SES barriers. Addressing SES disparities and fostering medical trust may enhance future COVID‐19 vaccination uptake rates for this high‐risk group.


  • Alcohol and Cannabis Use Associated with Cardiometabolic Biomarkers among “All of Us” Cancer Survivors

    by Angel Arizpe, Tiffany M. Chapman, Claudia Rodriguez, Alberto Carvajal, Katelyn J. Queen, Stephanie Navarro, Carol Y. Ochoa-Dominguez, Sue E. Kim, Claudia M. Toledo-Corral, Albert J. Farias

    Background: Cancer survivors are at increased risk for cardiometabolic comorbidities following cancer treatment, which may be further exacerbated by cannabis and alcohol use. We aimed to examine the direct relationships of cannabis, alcohol, and the co-use of both substances with cardiometabolic risk factors and to explore disparities by race/ethnicity and sex. Methods: Cross-sectional data were extracted from adult cancer survivors in the “All of Us” from 2018 to 2022. Cannabis use was defined as occasional or frequent/regular cannabis use (vs. never) in the past 3 months and hazardous alcohol intake (AUDIT-C >3 for females; AUDIT-C >4 for males) versus nonhazardous in the past year, respectively. Co-use was defined as participants who engaged in regular cannabis and hazardous alcohol intake. We identified binary cardiovascular, immune, and metabolic system biomarkers, with high values defined by clinically established cutoffs or >75th percentile. We used multivariable logistic regression adjusting for sociodemographic and clinical factors. Results: In our sample (N = 7,054), 7.6% were Hispanic, 6.2% were Black, and 86.2% were White cancer survivors. Less than 5% of Hispanic and White survivors reported substance co-use compared with 7% of Black survivors. Compared with never-users, co-users were 1.58 (95% confidence interval, 1.14–2.19) more likely to have high blood pressure. No significant associations were found between co-use and immune biomarkers or sex differences. Conclusions: Co-use of cannabis and hazardous alcohol may worsen high blood pressure in survivors, who are at higher risk for cardiometabolic comorbidities. Impact: The study investigates substance use and cardiometabolic biomarkers, urging much research on their effects on cancer survivors.


  • Latino Enclaves and Healthcare Accessibility: An Ecologic Study Across Five States

    by Alice Guan, Salma Shariff-Marco, Kevin A. Henry, Katherine Lin, Dan Meltzer, Alison J. Canchola, Angel Arizpe, Aniruddha B. Rathod, Amy E. Hughes, Candyce H. Kroenke, et al.

    Hispanic or Latino populations (hereafter, "Latinos") are a rapidly expanding U.S. demographic and have documented inequities in preventable diseases and conditions. Many Latinos reside in ethnic enclaves, and understanding the context and healthcare accessibility within these places is critical. This study described the neighborhood social and built environment attributes of Latino enclaves and evaluated associations between enclaves and geographic healthcare accessibility. Cross-sectional ecologic analysis. Our unit of analysis was all neighborhoods (n ~ 20,000 census tracts) in California, Florida, New Jersey, New York, and Texas in years 2000 and 2010. The primary exposure of interest, "Latino enclaves," was defined using neighborhood-level data on the percentage of Latino residents, foreign-born Latinos, Spanish speakers with limited English proficiency, and linguistically isolated Spanish-speaking households. The primary outcome was a neighborhood-level measure of geographic healthcare accessibility of primary care physicians, which accounted for both the supply of physicians and population demand for healthcare (i.e., population size within driving distance). Approximately 30% of neighborhoods were classified as Latino enclaves, 87% of which were enclaves in both 2000 and 2010. Compared with non-enclaves, Latino enclaves had more markers of structural disadvantage including having higher proportions of poverty, uninsured individuals, crowded housing, and higher crime scores. Results from multivariable models suggest that more culturally distinct neighborhoods (i.e., higher enclave score) had lower healthcare accessibility, though when stratified, this association persisted only in high (≥ 20%) poverty neighborhoods. This study highlights several neighborhood structural disadvantages within Latino enclaves, including higher poverty, uninsured individuals, and crime compared to non-enclave neighborhoods. Moreover, our findings point to the need for interventions aimed at improving healthcare accessibility particularly within socioeconomically disadvantaged Latino enclaves. Addressing these inequities demands multifaceted approaches that consider both social and structural factors to ensure equitable healthcare access for Latino populations.